MTM is a global biotech pioneer celebrated for its uniquely collaborative culture.
Run by entrepreneurs for entrepreneurs, we specialise in co-creating and scaling companies within our global ecosystem. We blend experienced drug discovery with agile operations to foster breakthroughs and deliver transformative medicines.
For more information, visit the website or email enquiries@m2m.bio.
Company Details
- Employees
- 50
- Founded
- 2015
- Address
- 99 Park Drive, Oxford,england Ox14 4ry,united Kingdom
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- molecule2medicine.com
- Keywords
- Biotechnology, Pharmaceuticals, Drug Development, Commercialisation, Corporate Governance, Due Diligence and Expert Opinion Services, Back Office Support for Virtual and Semi-VIrtual Companies and Teams, Clinical Development, Drug Discovery.
- HQ
- Oxford, England
Molecule To Medicine Questions
Molecule To Medicine's website is molecule2medicine.com
Molecule To Medicine's LinkedIn profile is https://uk.linkedin.com/company/moleculetomedicine
Molecule To Medicine has
50 employees.
View email and phone details for 50
employees at Molecule To Medicine.
Molecule To Medicine's industry is
Biotechnology Research
Molecule To Medicine's top competitors are
Curlew Bio,
Quell Therapeutics,
Enara Bio,
Greywolf Therapeutics,
Lucia Bio,
Vertex Pharmaceuticals,
Pathios Therapeutics,
Thirtyfivebio,
Uniquest,
Melio Bio.
Molecule To Medicine's categories are Biotechnology Research
Molecule To Medicine's founding year is 2015
